Replies to post #1 on Seelos Therapeutics (SEEL)

[ALERTS100%to10000%GAIN]

SEEL~~Following the reverse stock split and closing of the merger, there are approximately 6,221,822 shares of the combined company’s common stock outstanding,

[ALERTS100%to10000%GAIN]

SEEL~~ Cash, cash equivalents and short-term investments for the combined company at the closing were approximately $18 million, prior to payment of transaction costs.